[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@zz185901 Bipolar Economics
Bipolar Economics posts on X about $nvo, insurance, $pep, weight loss the most. They currently have XX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX +488%
- X Month XXXXX +303%
- X Months XXXXXX +408%
Mentions: X #
- X Week XX +122%
- X Month XX +42%
- X Months XX +200%
Followers: XX #
- X Week XX no change
- X Month XX -XX%
- X Months XX +59%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks XXXXX% finance XXXX%
Social topic influence $nvo #38, insurance #1720, $pep #431, weight loss 1.96%, $lly 1.96%, investments 1.96%, up the 1.96%, away from 1.96%, admin 1.96%, the only XXXX%
Top accounts mentioned or mentioned by @grok @semajgalbert47 @jokaqarmy1 @rhebam99173 @milli1548712 @iknowbelphegor @hawkishskip @jacksonhinklle @shaykhsulaiman @rvwindfield @repgregmurphy @abrahamhamadeh @actbrigitte @dipaolajoe @daltybrewer @vladtheinflator
Top assets mentioned Novo-Nordisk (NVO) PepsiCo, Inc. (PEP) Eli Lilly and Company (LLY)
Top Social Posts #
Top posts by engagements in the last XX hours
"If the deal achieved labels Ozempic as a weight loss drug the access to previously locked off segments of the market becomes unleashed. Giving up some margin in exchange can further solidify its XX% market share may make $NVO the Coke vs Pepsi $LLY of the pharmaceutical industry"
X Link @zz185901 2025-10-17T12:29Z XX followers, XXX engagements
"MTG has a track record of 30%+ return on her investments annually. The trade on $NVO was timely in that a deal is expected to be announced by November 1st. If this track record holds we are looking at $70+ per share within a small time frame"
X Link @zz185901 2025-10-17T13:18Z XX followers, XXX engagements
"Heres what everyone missed $NVO just got legitimated as a broad American need to combat obesity. This means wider accessibility and insurance companies have to approve requests moving forward"
X Link @zz185901 2025-10-16T21:08Z XX followers, 4510 engagements
"Marjorie Taylor Greene buys more $NVO"
X Link @zz185901 2025-10-17T08:49Z XX followers, XXX engagements
"Lets cut through the noise: The weight problem is so bad in the US XX% of all soldiers are in urgent need of Ozempic. By declaring this as an essential drug for obesity now 800k soldiers can have access to it through the TRICARE system (health insurance) $NVO"
X Link @zz185901 2025-10-17T10:42Z XX followers, XXX engagements
"40% of all military personnel spouses are also obese implying another 300k+ more customers that will gain access to Ozempic now that Trump has endorsed it. This combined with active service members thats over a Million users that will now gain access to Ozempic. $NVO"
X Link @zz185901 2025-10-17T11:37Z XX followers, XXX engagements
"75% of all current Ozempic requests are being denied by insurance providers. This means as it stands Ozempic usage may rise x4 on current demand alone. $NVO will need to x4 their production capacity at the bare minimum"
X Link @zz185901 2025-10-17T11:42Z XX followers, XXX engagements
"Lets sum it up. The fundamental changes to healthcare are geared towards which pocket pays for what rather than actual price compression. If compression occur its in exchange for larger market access and regulatory expediency"
X Link @zz185901 2025-10-17T13:13Z XX followers, XX engagements
"Novo Nordisk $NVO is the only player in the market with oral options and has expanded successfully across use cases with robust approvals where rivals maybe many years away from catching up. Next big one is oral Wegovy. That will slap"
X Link @zz185901 2025-10-18T15:56Z XX followers, XXX engagements